United States Prostacyclin Analog Market Report 2017

United States Prostacyclin Analog Market Report 2017

1 Prostacyclin Analog Overview

1.1 Product Overview and Scope of Prostacyclin Analog

1.2 Classification of Prostacyclin Analog

1.2.1 Type I

1.2.2 Type II

1.3 Application of Prostacyclin Analog

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Prostacyclin Analog (2012-2022)

1.4.1 United States Prostacyclin Analog Sales and Growth Rate (2012-2022)

1.4.2 United States Prostacyclin Analog Revenue and Growth Rate (2012-2022)

2 United States Prostacyclin Analog Competition by Manufacturers

2.1 United States Prostacyclin Analog Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Prostacyclin Analog Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Prostacyclin Analog Average Price by Manufactures (2015 and 2016)

2.4 Prostacyclin Analog Market Competitive Situation and Trends

2.4.1 Prostacyclin Analog Market Concentration Rate

2.4.2 Prostacyclin Analog Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Prostacyclin Analog Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Prostacyclin Analog Sales and Market Share by States (2012-2017)

3.2 United States Prostacyclin Analog Revenue and Market Share by States (2012-2017)

3.3 United States Prostacyclin Analog Price by States (2012-2017)

4 United States Prostacyclin Analog Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Prostacyclin Analog Sales and Market Share by Type (2012-2017)

4.2 United States Prostacyclin Analog Revenue and Market Share by Type (2012-2017)

4.3 United States Prostacyclin Analog Price by Type (2012-2017)

4.4 United States Prostacyclin Analog Sales Growth Rate by Type (2012-2017)

5 United States Prostacyclin Analog Sales (Volume) by Application (2012-2017)

5.1 United States Prostacyclin Analog Sales and Market Share by Application (2012-2017)

5.2 United States Prostacyclin Analog Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Prostacyclin Analog Manufacturers Profiles/Analysis

6.1 Actelion Pharmaceuticals

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Prostacyclin Analog Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Actelion Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 United Therapeutics Corporation

6.2.2 Prostacyclin Analog Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 United Therapeutics Corporation Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Gilead

6.3.2 Prostacyclin Analog Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Gilead Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Bayer AG

6.4.2 Prostacyclin Analog Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Bayer AG Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 SteadyMed

6.5.2 Prostacyclin Analog Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 SteadyMed Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 GlaxoSmithKline

6.6.2 Prostacyclin Analog Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 GlaxoSmithKline Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Pfizer

6.7.2 Prostacyclin Analog Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Pfizer Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Reata Pharmaceuticals

6.8.2 Prostacyclin Analog Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Reata Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Arena Pharmaceuticals

6.9.2 Prostacyclin Analog Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Arena Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Merck

6.10.2 Prostacyclin Analog Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Merck Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Prostacyclin Analog Manufacturing Cost Analysis

7.1 Prostacyclin Analog Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Prostacyclin Analog

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Prostacyclin Analog Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Prostacyclin Analog Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Prostacyclin Analog Market Forecast (2017-2022)

11.1 United States Prostacyclin Analog Sales, Revenue Forecast (2017-2022)

11.2 United States Prostacyclin Analog Sales Forecast by Type (2017-2022)

11.3 United States Prostacyclin Analog Sales Forecast by Application (2017-2022)

11.4 Prostacyclin Analog Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Prostacyclin Analog

Table Classification of Prostacyclin Analog

Figure United States Sales Market Share of Prostacyclin Analog by Type in 2015

Table Application of Prostacyclin Analog

Figure United States Sales Market Share of Prostacyclin Analog by Application in 2015

Figure United States Prostacyclin Analog Sales and Growth Rate (2012-2022)

Figure United States Prostacyclin Analog Revenue and Growth Rate (2012-2022)

Table United States Prostacyclin Analog Sales of Key Manufacturers (2015 and 2016)

Table United States Prostacyclin Analog Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Prostacyclin Analog Sales Share by Manufacturers

Figure 2016 Prostacyclin Analog Sales Share by Manufacturers

Table United States Prostacyclin Analog Revenue by Manufacturers (2015 and 2016)

Table United States Prostacyclin Analog Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Prostacyclin Analog Revenue Share by Manufacturers

Table 2016 United States Prostacyclin Analog Revenue Share by Manufacturers

Table United States Market Prostacyclin Analog Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Prostacyclin Analog Average Price of Key Manufacturers in 2015

Figure Prostacyclin Analog Market Share of Top 3 Manufacturers

Figure Prostacyclin Analog Market Share of Top 5 Manufacturers

Table United States Prostacyclin Analog Sales by States (2012-2017)

Table United States Prostacyclin Analog Sales Share by States (2012-2017)

Figure United States Prostacyclin Analog Sales Market Share by States in 2015

Table United States Prostacyclin Analog Revenue and Market Share by States (2012-2017)

Table United States Prostacyclin Analog Revenue Share by States (2012-2017)

Figure Revenue Market Share of Prostacyclin Analog by States (2012-2017)

Table United States Prostacyclin Analog Price by States (2012-2017)

Table United States Prostacyclin Analog Sales by Type (2012-2017)

Table United States Prostacyclin Analog Sales Share by Type (2012-2017)

Figure United States Prostacyclin Analog Sales Market Share by Type in 2015

Table United States Prostacyclin Analog Revenue and Market Share by Type (2012-2017)

Table United States Prostacyclin Analog Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Prostacyclin Analog by Type (2012-2017)

Table United States Prostacyclin Analog Price by Type (2012-2017)

Figure United States Prostacyclin Analog Sales Growth Rate by Type (2012-2017)

Table United States Prostacyclin Analog Sales by Application (2012-2017)

Table United States Prostacyclin Analog Sales Market Share by Application (2012-2017)

Figure United States Prostacyclin Analog Sales Market Share by Application in 2015

Table United States Prostacyclin Analog Sales Growth Rate by Application (2012-2017)

Figure United States Prostacyclin Analog Sales Growth Rate by Application (2012-2017)

Table Actelion Pharmaceuticals Basic Information List

Table Actelion Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Actelion Pharmaceuticals Prostacyclin Analog Sales Market Share (2012-2017)

Table United Therapeutics Corporation Basic Information List

Table United Therapeutics Corporation Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table United Therapeutics Corporation Prostacyclin Analog Sales Market Share (2012-2017)

Table Gilead Basic Information List

Table Gilead Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table Gilead Prostacyclin Analog Sales Market Share (2012-2017)

Table Bayer AG Basic Information List

Table Bayer AG Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bayer AG Prostacyclin Analog Sales Market Share (2012-2017)

Table SteadyMed Basic Information List

Table SteadyMed Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table SteadyMed Prostacyclin Analog Sales Market Share (2012-2017)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table GlaxoSmithKline Prostacyclin Analog Sales Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table Pfizer Prostacyclin Analog Sales Market Share (2012-2017)

Table Reata Pharmaceuticals Basic Information List

Table Reata Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table Reata Pharmaceuticals Prostacyclin Analog Sales Market Share (2012-2017)

Table Arena Pharmaceuticals Basic Information List

Table Arena Pharmaceuticals Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table Arena Pharmaceuticals Prostacyclin Analog Sales Market Share (2012-2017)

Table Merck Basic Information List

Table Merck Prostacyclin Analog Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Prostacyclin Analog Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Prostacyclin Analog

Figure Manufacturing Process Analysis of Prostacyclin Analog

Figure Prostacyclin Analog Industrial Chain Analysis

Table Raw Materials Sources of Prostacyclin Analog Major Manufacturers in 2015

Table Major Buyers of Prostacyclin Analog

Table Distributors/Traders List

Figure United States Prostacyclin Analog Production and Growth Rate Forecast (2017-2022)

Figure United States Prostacyclin Analog Revenue and Growth Rate Forecast (2017-2022)

Table United States Prostacyclin Analog Production Forecast by Type (2017-2022)

Table United States Prostacyclin Analog Consumption Forecast by Application (2017-2022)

Table United States Prostacyclin Analog Sales Forecast by States (2017-2022)

Table United States Prostacyclin Analog Sales Share Forecast by States (2017-2022)